awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30620954-2CAA6709-AEDB-4A30-9E2B-FD87776A392A
Q30620954-2CAA6709-AEDB-4A30-9E2B-FD87776A392A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30620954-2CAA6709-AEDB-4A30-9E2B-FD87776A392A
Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint
P2860
Q30620954-2CAA6709-AEDB-4A30-9E2B-FD87776A392A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30620954-2CAA6709-AEDB-4A30-9E2B-FD87776A392A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f220fa325843a2a1e8aab203f3416424646d615f
P2860
Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.